Pharma/Biotech Deals: Are Today’s Collaborations Tomorrow’s Acquisitions?
Executive Summary
Big pharma and biotech companies are increasingly looking at collaborations as a pathway to acquisition, Kirkpatrick & Lockhart attorney Eileen Smith Ewing said at the Biotechnology Industry Organization annual meeting in Washington, D.C. June 23